Children's zyrtec products

ZYRTEC®

Recommend Children’s ZYRTEC® right at the start of symptoms* to provide proven effective allergy relief for kids ages 2+

*ZYRTEC® relieves sneezing, runny nose, itchy, watery eyes, and itching of the nose or throat.

Why Children’s ZYRTEC®?

Children’s ZYRTEC® effectively relieves children’s worst allergy symptoms: sneezing, runny nose, itchy, watery eyes, and itching of the nose or throat. 

Count on Children’s ZYRTEC® to provide 24-hour relief with convenient once-daily dosing. The syrup comes in kid-friendly flavors, grape and bubble gum, both sugar- and dye-free. While the convenient dissolve tabs melt in the mouth—so there's no need for water.

ZYRTEC® is the #1 pediatrician recommended brand for children's allergies.†

†Among OTC oral antihistamines.

Efficacy/ 2-6

Powerful symptom response¹ in patients ages 2 to 6 years old

 

Zyrtec efficacy

Children’s ZYRTEC® 5 mg provides a significant impact1* on allergies in patients ages 2 to 6 years old with seasonal allergic rhinitis (SAR)

Percentage of children demonstrating ≥50% improvement from baseline SAR symptoms over 2 weeks.

Randomized, placebo-controlled study of children aged 2 to 6 years with SAR during a 2-week period. Primary endpoint was the change in Total Symptom Score Complex from baseline.

*Significant vs placebo.

†ZYRTEC® 5 mg vs placebo ratio at ≥50% reduction is 1.84-fold.

Efficacy/ 6-12

Powerful symptom response¹ in patients ages 6 to 12 years old

 

Zyrtec efficacy trials with placebo

Children’s ZYRTEC® 10 mg provides a significant impact*1 on allergies in patients ages 6 to 12 years old with seasonal allergic rhinitis (SAR)

Percentage of children demonstrating ≥50% improvement from baseline SAR symptoms over 2 weeks.

Randomized, placebo-controlled studies of children aged 6 to 12 years with SAR during a 2-week period. Primary endpoint was the change in Total Symptom Score Complex from baseline.

*Significant vs placebo.

†ZYRTEC® 10 mg vs placebo ratio at ≥50% reduction is 1.88-fold in Study 1 and 1.42-fold in Study 2.

Consistent relief of seasonal allergic rhinitis symptoms2

zyrtec chart

Reduction from baseline in Total Symptom Severity Complex (TSSC)*†

Improvement maintained throughout 2 weeks of regular use

  • Percent reductions from baseline TSSC score were 37% and 40%, respectively, after 2 weeks of treatment in the 10-mg group
  • Percent reductions from baseline TSSC score were 63% and 40%, respectively, after 2 weeks of treatment in the 5-mg group

All studies are multicenter, randomized, placebo-controlled, double-blind; children ages 2 to 11 years with previous diagnosis of SAR, and adequate minimum duration (2 weeks).

*TSSC = Total Symptom Severity Complex.

†Adjusted mean change relative to baseline.

Symptom relief that is generally well tolerated1

In clinical trials of children ages 6 to 11 years

4.2% of patients taking ZYRTEC® 10 mg reported somnolence (n=215) vs 1.3% with placebo (n=309)¹

≤1% of ZYRTEC® patients discontinued due to somnolence¹

 

Want to learn more about Children's ZYRTEC®?

Learn more

 

Pediatric BundleBox J&J

Monthly Pediatric BundleBox

Discover samples and resources for your patients

Open box

‖The information contained in the Allergy Forecast is provided by third parties for information purposes only, and does not represent a guarantee of accuracy or an endorsement, direct or implied, by Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division.

REFERENCES: 1. Data on file. Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division. 2. Urdaneta ER, Przygoda PA, Lin CL, et al. Regular use of cetirizine demonstrates consistent relief from symptoms of seasonal allergic rhinitis in children. J Allergy Clin Immunol. 2011;127(suppl 2):AB 202.